COMMUNIQUÉS West-GlobeNewswire

Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference
06/05/2026
ROCKVILLE, Md., May 06, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
DLH Reports Fiscal 2026 Second Quarter Results
06/05/2026
ATLANTA, May 06, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science [...]
Bionano Announces Leadership Transition
06/05/2026
SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano’s Board of Directors, has been appointed interim president and chief [...]
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance
06/05/2026
MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, [...]
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026
06/05/2026
PiNACLE pivotal clinical trial evaluating ronde-cel in patients with LBCL in third- or later-line setting on track to report additional data in second half of 2026, with pivotal data expected mid-2027 and BLA submission [...]
Entrada Therapeutics to Announce Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study on May 7, 2026
06/05/2026
BOSTON, May 06, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) will announce topline results from Cohort 1 of the double-blind, placebo-controlled, multiple ascending dose portion of the Phase 1/2 [...]
Alvotech Q1 2026 Financial Results
06/05/2026
REYKJAVIK, Iceland, May 06, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights A supplemental long ‑ form earnings release providing additional operational [...]
Sage Dental Expands National Reach Through Strategic Partnership with Curaechoice
06/05/2026
Partnership enhances access to affordable, comprehensive dental care for members and their families across the Southeast and beyond Birmingham, Alabama, May 06, 2026 (GLOBE NEWSWIRE) -- Sage Dental, a premier dental [...]
Diathrive Health and KardiaComplete Announce Strategic Partnership to Address Cardiometabolic Risk
06/05/2026
MOUNTAIN VIEW, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Diathrive Health, the leader in chronic disease management, and AliveCor, the global leader in AI-powered cardiology, today announced a strategic partnership to [...]
Guidance updated to reflect Hearing business being treated as discontinued operations
06/05/2026
Following the company announcement on March 16, 2026 (“GN Store Nord A/S enters into agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion”), GN is now reintroducing a profitability guidance for [...]
Renewa Micro-Infusion System Claims Evaluated: The Painless Skin Microneedling Device for At-Home Face Lift Treatment
06/05/2026
How the Renewa Skin 0.3mm Gold-Needle Micro-Infusion Device Is Designed for Fine Lines, Skin Firmness, and At-Home Cosmetic Skincare for Women Over 50 in 2026 Sheridan, WY, May 06, 2026 (GLOBE NEWSWIRE) -- Results may [...]
Walmart Canada et Children's Miracle Network mobilisent les Canadiens pour soutenir la santé des enfants et donnent le coup d’envoi de la campagne annuelle de collecte de fonds
06/05/2026
Walmart lance la campagne du printemps avec un don d'un million de dollars pour soutenir les fondations d'hôpitaux pour enfants MISSISSAUGA, Ontario, 06 mai 2026 (GLOBE NEWSWIRE) -- Tandis que le printemps fleurit à [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
06/05/2026
Nantes, le 6 mai 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), une société de [...]
Robotic Companion Pets from Ageless Innovation Reach 750,000 Adoptions Supporting Well-Being for Older Adults
06/05/2026
Ageless Innovation marks a major milestone highlighting its ongoing commitment to older adults and caregivers through the power of play PAWTUCKET, R.I., May 06, 2026 (GLOBE NEWSWIRE) -- Ageless Innovation, a global [...]
Growth in revenue and operating profit
06/05/2026
Trading statement for Q3 2025/26 (1 January – 31 March 2026) Growth in revenue and operating profit ChemoMetec’s revenue was up by 15% in the third quarter of 2025/26 to DKK 142.3 million from DKK 124.2 million in the [...]
Interim Report Q1 2026: Navigating challenging markets in EMEA and taking actions to adjust the cost structure for future healthy margins
06/05/2026
Highlights Following the announcement of GN Store Nord’s divestment of its Hearing division, the financial performance related hereto is treated as discontinued operations in the Q1 2026 report and until closing of the [...]
CARBOGEN AMCIS Shanghai Site achieves successful outcome in Unannounced NMPA GMP Inspection
06/05/2026
BUBENDORF, Switzerland, May 06, 2026 (GLOBE NEWSWIRE) -- CARBOGEN AMCIS , a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, today announces its [...]
Walmart Canada and Children’s Miracle Network Rally Canadians to Support Kids’ Health, Kick Off Annual Fundraising Campaign
06/05/2026
Walmart Canada leads spring campaign with a $1 million donation to support children’s hospital foundations MISSISSAUGA, Ontario, May 06, 2026 (GLOBE NEWSWIRE) -- As spring blooms across the country, Walmart Canada and [...]
Trethera To Present Optic Neuritis Research at Los Angeles Bioscience Ecosystem Summit 2026
06/05/2026
LOS ANGELES, May 06, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer, autoimmune, and neuroimmune diseases, will [...]

Pages